ArticleEMBO molecular medicine2020

Adaptive RSK-EphA2-GPRC5A signaling switch triggers chemotherapy resistance in ovarian cancer.

Lidia Moyano-Galceran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.